Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 2
1979 1
1980 1
1981 1
1982 2
1983 1
1984 1
1985 4
1986 1
1987 1
1988 3
1990 1
1992 1
1993 1
1994 1
1995 1
1996 1
1997 1
1998 3
2000 3
2001 3
2002 5
2003 4
2004 2
2005 3
2006 2
2007 2
2008 4
2009 6
2010 6
2011 2
2012 5
2013 2
2014 4
2015 7
2016 2
2018 2
2019 4
2020 3
2021 6
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.
Nichols DP, Paynter AC, Heltshe SL, Donaldson SH, Frederick CA, Freedman SD, Gelfond D, Hoffman LR, Kelly A, Narkewicz MR, Pittman JE, Ratjen F, Rosenfeld M, Sagel SD, Schwarzenberg SJ, Singh PK, Solomon GM, Stalvey MS, Clancy JP, Kirby S, Van Dalfsen JM, Kloster MH, Rowe SM; PROMISE Study group. Nichols DP, et al. Am J Respir Crit Care Med. 2022 Mar 1;205(5):529-539. doi: 10.1164/rccm.202108-1986OC. Am J Respir Crit Care Med. 2022. PMID: 34784492 Free PMC article.
Conclusions: ETI by clinical prescription provided large improvements in lung function, respiratory symptoms, and BMI in a diverse population naive to modulator drug therapy, using existing two-drug combinations, or using ivacaftor alone. Each group also experienced signif …
Conclusions: ETI by clinical prescription provided large improvements in lung function, respiratory symptoms, and BMI in a diverse populatio …
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, Weaver D, Yaffe MJ, Yeh JM, Couch FJ, Hu C, Kraft P, Polley EC, Mandelblatt JS, Kurian AW, Robson ME; Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET), in collaboration with the Breast Cancer Surveillance Consortium (BCSC), and the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium. Lowry KP, et al. JAMA Oncol. 2022 Apr 1;8(4):587-596. doi: 10.1001/jamaoncol.2021.6204. JAMA Oncol. 2022. PMID: 35175286 Free PMC article.
INTERVENTIONS: Screening strategies with combinations of annual mammography alone and with MRI starting at age 25, 30, 35, or 40 years until age 74 years. ...RESULTS: The mean model-estimated lifetime breast cancer risk was 20.9% (18.1%-23.7%) for women with ATM pathogenic …
INTERVENTIONS: Screening strategies with combinations of annual mammography alone and with MRI starting at age 25, 30, 35, or 40 year …
Uterine transplantation and donation in transgender individuals; proof of concept.
Jahromi AH, Horen SR, Dorafshar AH, Seu ML, Radix A, Anderson E, Green J, Fraser L, Johannesson L, Testa G, Schechter LSM, Schechter L. Jahromi AH, et al. Int J Transgend Health. 2021 May 28;22(4):349-359. doi: 10.1080/26895269.2021.1915635. eCollection 2021. Int J Transgend Health. 2021. PMID: 37808528 Free PMC article. No abstract available.
Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
Bennett M, Schechter GP. Bennett M, et al. Semin Hematol. 2010 Apr;47(2):143-7. doi: 10.1053/j.seminhematol.2010.01.004. Semin Hematol. 2010. PMID: 20350661 Review.
Since approval of rituximab, treatment of such patients with the anti-CD20 antibody both alone or in combination with chemotherapy has shown remarkable responses. ...
Since approval of rituximab, treatment of such patients with the anti-CD20 antibody both alone or in combination with chemotherapy ha …
Exercise intolerance and the impact of physical activity in children treated with hematopoietic stem cell transplantation.
West SL, Gassas A, Schechter T, Egeler RM, Nathan PC, Wells GD. West SL, et al. Pediatr Exerc Sci. 2014 Aug;26(3):358-64. doi: 10.1123/pes.2013-0156. Epub 2014 Apr 10. Pediatr Exerc Sci. 2014. PMID: 24721685 Review.
One predominant consequence of childhood cancer therapy is increased physical morbidity, which is worse in pediatric SCT recipients compared with children treated with chemotherapy or radiation alone. There are many factors that contribute to exercise intolerance and reduc …
One predominant consequence of childhood cancer therapy is increased physical morbidity, which is worse in pediatric SCT recipients compared …
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.
Rosenberg AJ, Liao CY, Karrison T, de Souza JA, Worden FP, Libao B, Krzyzanowska MK, Hayes DN, Winquist E, Saloura V, Prescott K, Villaflor VM, Seiwert TY, Schechter RB, Stadler WM, Cohen EEW, Vokes EE. Rosenberg AJ, et al. Ann Oncol. 2023 Aug;34(8):714-722. doi: 10.1016/j.annonc.2023.05.002. Epub 2023 May 13. Ann Oncol. 2023. PMID: 37182801 Clinical Trial.
PATIENTS AND METHODS: In this multicenter, open-label, randomized, phase II clinical trial, 110 patients were enrolled and randomized to cediranib alone or cediranib with lenalidomide. The primary endpoint was progression-free survival (PFS). ...
PATIENTS AND METHODS: In this multicenter, open-label, randomized, phase II clinical trial, 110 patients were enrolled and randomized to ced …
ACR-ABS-ASTRO practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy.
Harkenrider MM, Albuquerque K, Brown D, Kamrava M, King M, Mourtada F, Orio P, Patel R, Price M, Rassiah P, Solanki AA, Small W Jr, Schechter NR. Harkenrider MM, et al. Brachytherapy. 2021 Nov-Dec;20(6):1071-1082. doi: 10.1016/j.brachy.2021.08.009. Epub 2021 Sep 26. Brachytherapy. 2021. PMID: 34588143
RESULTS: Brachytherapy is a radiotherapeutic modality in which radionuclide or electronic sources are used to deliver a radiation dose at a distance of up to a few centimeters by surface, intracavitary, intraluminal, or interstitial application. Brachytherapy alone or comb …
RESULTS: Brachytherapy is a radiotherapeutic modality in which radionuclide or electronic sources are used to deliver a radiation dose at a …
A community-based asthma program: Study design and methods of RVA Breathes.
Everhart RS, Mazzeo SE, Corona R, Holder RL, Thacker LR 2nd, Schechter MS. Everhart RS, et al. Contemp Clin Trials. 2020 Oct;97:106121. doi: 10.1016/j.cct.2020.106121. Epub 2020 Aug 19. Contemp Clin Trials. 2020. PMID: 32822827 Free PMC article.
Disparities in pediatric asthma morbidity and healthcare utilization exist on the basis of race, ethnicity, environment, and income; interventions are needed to address these inequities. ...Participants will be randomized to one of three groups: asthma education + home …
Disparities in pediatric asthma morbidity and healthcare utilization exist on the basis of race, ethnicity, environment, and income; …
Smoke-Free Home Rules and Association with Child Secondhand Smoke Exposure among Mother-Child Dyad Relationships.
Fallavollita WL, Do EK, Schechter JC, Kollins SH, Zheng JJ, Qin J, Maguire RL, Hoyo C, Murphy SK, Fuemmeler BF. Fallavollita WL, et al. Int J Environ Res Public Health. 2021 May 14;18(10):5256. doi: 10.3390/ijerph18105256. Int J Environ Res Public Health. 2021. PMID: 34069235 Free PMC article.
Smoke-free home rules restrict smoking in the home, but biomarkers of secondhand smoke exposure are needed to help understand the association between smoke-free homes and child secondhand smoke exposure. ...After controlling for smokers in the household, home …
Smoke-free home rules restrict smoking in the home, but biomarkers of secondhand smoke exposure are needed to help understand …
Identifying the Best Questions for Rapid Screening of Secondhand Smoke Exposure Among Children.
Ksinan AJ, Sheng Y, Do EK, Schechter JC, Zhang JJ, Maguire RL, Hoyo C, Murphy SK, Kollins SH, Rubin B, Fuemmeler BF. Ksinan AJ, et al. Nicotine Tob Res. 2021 Jun 8;23(7):1217-1223. doi: 10.1093/ntr/ntaa254. Nicotine Tob Res. 2021. PMID: 33249470 Free PMC article.
RESULTS: Answering positively to at least one of the two final items ("During the past 30 days, did you smoke cigarettes at all?" and "Has anyone, including yourself, smoked tobacco in your home in the past 7 days?") showed area under the curve = .82, and good specificity …
RESULTS: Answering positively to at least one of the two final items ("During the past 30 days, did you smoke cigarettes at all?" and "Has a …
106 results